Teriparatide Dosage Guide
Complete guide to Teriparatide dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
20 mcg
Frequency
Once per day
Route
subcutaneous
Cycle Length
52–104 weeks
Reconstitution
Vial Size
1 mg
BAC Water
3.0 ml
Concentration
333.333 mcg/ml
Detailed Dosage Information
20mcg subcutaneously once daily.
Maximum treatment duration of 2 years due to theoretical osteosarcoma risk from rat studies.
Administration Method
Subcutaneous injection in thigh or abdomen once daily. Delivered via multi-dose pen. Should sit or lie down after injection due to orthostatic hypotension risk.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 333.333 mcg/ml
Volume to inject: 0.060 ml
Syringe units: 6.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Teriparatide defaults. Adjust values as needed.
Side Effects to Monitor
Orthostatic hypotension, leg cramps, nausea, dizziness, headache, and injection site reactions. Transient hypercalcemia possible.
Safety Considerations & Risks
Boxed warning for osteosarcoma risk (seen in rat studies at high doses). Contraindicated in Paget's disease, unexplained elevated ALP, prior bone radiation, or bone metastases.